Número de publicaciones
572
Buscador de publicaciones
  • Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X

    Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 24 247-253. .

  • González Cao M; Puig S; Malvehy J; Herrero JE; MARTI LABORDA, ROSA MARIA; Conill C; Sánchez M; Mellado B; Gascón P; Castel T

    Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial.

    CLINICAL & TRANSLATIONAL ONCOLOGY 7 250-254. .

  • Velasco A; Palomar-Asenjo V; Gañan L; Catasus L; Llecha N; Panizo A; Palomar-Garcia V; Quer M; Matias-Guiu X

    Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.

    Diagnostic Molecular Pathology 14 109-114. .

  • Bielsa S; Baradad M; MARTI LABORDA, ROSA MARIA; Casanova JM

    Síndrome de Sweet con lesiones ampollosas.

    ACTAS DERMO-SIFILIOGRAFICAS 96 315-316. .

  • Irving, JA; Catasus, L; Gallardo, A; Bussaglia, E; Romero, M; Matias-Guiu, X; Prat, J

    Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis

    HUMAN PATHOLOGY 36 605-619. .

    [doi:10.1016/j.humpath.2005.03.005]

  • Velasco, A; Palomar-Asenjo, V; Ganan, L; Catasus, L; Llecha, N; Panizo, A; Palomar-Garcia, V; Quer, M; Matias-Guiu, X

    Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma - Description of one novel germline mutation

    Diagnostic Molecular Pathology 14 109-114. .

    [doi:10.1097/01.pas.0000158987.07907.7e]

  • Pallares, J; Bussaglia, E; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Sanchez-Verde, L; Palacios, J; Prat, J; Matias-Guiu, X

    Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.

    Modern Pathology 18 719-727. .

    [doi:10.1038/modpathol.3800347]

  • Dolcet, X; Llobet, D; Pallares, J; Matias-Guiu, X

    NF-kB in development and progression of human cancer.

    VIRCHOWS ARCHIV 446 475-482. .

    [doi:10.1007/s00428-005-1264-9]

  • Puig, S; Malvehy, J; Badenas, C; Ruiz, A; Jimenez, D; Cuellar, F; Azon, A; Gonzalez, U; Castel, T; Campoy, A; Herrero, J; Marti, R; Brunet-Vidal, J; Mila, M

    Role of the CDKN2a locus in patients with multiple primary melanomas

    Journal of Clinical Oncology 23 3043-3051. .

    [doi:10.1200/JCO.2005.08.034]

  • Gutierrez, H; Hale, VA; Dolcet, X; Davies, A

    NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS.

    Development 132 1713-1726. .

    [doi:10.1242/dev.01702]

  • Isidro, ML; Diaz, PI; Matias-Guiu, X; Cordido, F

    Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma

    Journal Of Endocrinological Investigation 28 162-165. .

  • Domingo-Domenech, J; Molina, R; Castel, T; Montagut, C; Puig, S; Conill, C; Marti, R; Vera, M; Auge, JM; Malvehy, J; Grau, JJ; Gascon, P; Mellado, B

    Serum protein S-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon - Comparison with tyrosinase RT-PCR

    ONCOLOGY-BASEL 68 341-349. .

    [doi:10.1159/000086973]